Using PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy

被引：0
|
作者：
Anton, A. [1 ]
Ballok, Z. [2 ]
Bowden, P. [3 ]
Costello, T. [4 ,5 ]
Harewood, L. [4 ,7 ]
Corcoran, N. [4 ,5 ]
Dundee, P. [4 ,5 ]
Peters, J. [4 ]
Lawrentschuk, N. [6 ,8 ]
Troy, A. [6 ]
Webb, D. [6 ]
Chan, Y. [6 ]
See, A. [3 ]
Siva, S. [3 ,9 ]
Murphy, D. [8 ]
Hofman, M. S. [10 ]
Tran, B. [1 ,6 ,11 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Syst Biol & Personalised Med, Melbourne, Vic, Australia
[2] Healthcare Imaging Serv, Nucl Med, Melbourne, Vic, Australia
[3] ICON Canc Care, Radiat Oncol, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Urol, Melbourne, Vic, Australia
[5] Australian Prostate Ctr, Melbourne, Vic, Australia
[6] Epworth Healthcare, Urol, Melbourne, Vic, Australia
[7] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia
[8] Peter MacCallum Canc Ctr, Urol, Melbourne, Vic, Australia
[9] Peter MacCallum Canc Ctr, Radiat Oncol, Melbourne, Vic, Australia
[10] Peter MacCallum Canc Ctr, Nucl Med, Melbourne, Vic, Australia
[11] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
223P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Use of PSMA PET/CT to Assess Treatment Response Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer (MPC)
    Anton, Angelyn
    Hasan, Olfat Kamel
    Ballok, Zita
    Bowden, Patrick
    Costello, Tony
    Harewood, Laurence
    Corcoran, Niall
    Dundee, Phil
    Peters, Justin
    Lawrentschuk, Nathan
    Troy, Andrew
    Webb, David
    Chan, Yee
    See, Andrew
    Siva, Shankar
    Murphy, Declan
    Hofman, Michael S.
    Tran, Ben
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 43 - 43
  • [2] The role of PSMA PET-CT in patients with metastatic prostate cancer
    von Hardenberg, J.
    Buesing, K. -A.
    Nuhn, P.
    Ritter, M.
    RADIOLOGE, 2018, 58 (03): : 226 - 232
  • [3] The role of PSMA PET-CT in patients with metastatic prostate cancer
    von Hardenberg, J.
    Buesing, K. -A.
    Nuhn, P.
    Ritter, M.
    UROLOGE, 2017, 56 (11): : 1410 - 1416
  • [4] PSMA PET/CT and Therapy Response Evaluation in Metastatic Prostate Cancer: Is It Time to Surpass the Old Way?
    Evangelista, Laura
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 996 - 996
  • [5] Phase II trial of neoadjuvant chemohormonal therapy (NAC) in prostate cancer (PC) with response assessment using PSMA PET/MRI
    Kyriakopoulos, Christos
    Johnson, Brian
    Heninger, Erika
    Khemees, Tariq A.
    Roldan-Alzate, Alejandro
    Huang, Wei
    Beebe, David J.
    Emamekhoo, Hamid
    Wells, Shane A.
    Jarrard, David Frazier
    Cho, Steve Y.
    Lang, Joshua Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer
    Anton, Angelyn
    Kamel Hasan, Olfat
    Ballok, Zita
    Bowden, Patrick
    Costello, Anthony J.
    Harewood, Laurence
    Corcoran, Niall M.
    Dundee, Phil
    Peters, Justin S.
    Lawrentschuk, Nathan
    Troy, Andrew
    Webb, David
    Chan, Yee
    See, Andrew
    Siva, Shankar
    Murphy, Declan
    Hofman, Michael S.
    Tran, Ben
    BJU INTERNATIONAL, 2020, 126 (04) : 433 - 435
  • [7] Treatment response evaluation with PSMA-PET/CT in patients with metastatic prostate cancer, a subgroup analysis
    Kleiburg, F.
    De Geus-Oei, L. F.
    Luelmo, S. A. C.
    Toonen, F. A. J.
    Smit, F.
    Van der Hulle, T.
    Heijmen, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S497 - S497
  • [8] Therapy assessment in prostate cancer using choline and PSMA PET/CT
    Francesco Ceci
    Ken Herrmann
    Boris Hadaschik
    Paolo Castellucci
    Stefano Fanti
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 78 - 83
  • [9] Therapy assessment in prostate cancer using choline and PSMA PET/CT
    Ceci, Francesco
    Herrmann, Ken
    Hadaschik, Boris
    Castellucci, Paolo
    Fanti, Stefano
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S78 - S83
  • [10] Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
    Kelly, R.
    Wong, S. S. L.
    Shapiro, J.
    Weickhardt, A. J.
    Parente, P.
    Azad, A.
    Uccellini, A.
    Torres, J.
    Parnis, F.
    Kwan, E.
    Brown, S.
    Steer, C.
    Warren, M.
    Gibbs, P.
    Anton, A.
    Tran, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S1498 - S1499
12345